Instacart agreed to pay $60 million to settle an FTC lawsuit over alleged deceptive delivery promotions, refund barriers, and Instacart+ trial disclosures. The case signals tougher regulatory scrutiny of online delivery pricing and subscription practices.
Lululemon plans to enter six new international markets in 2026, leaning on global demand to offset slowing North American sales. The move highlights how international expansion and leadership change are central to the brand’s next phase of growth.
Mattel has appointed former Netflix and Disney executive Natalia Premovic as chief consumer products and experiences officer, signaling a deeper push to monetize its iconic IP through licensing, entertainment, and location-based experiences amid sales pressure.
The $950M deal to sell more than 100 J.C. Penney stores to Onyx Partners has fallen apart. The collapse highlights pricing risks, lender caution, and ongoing uncertainty around department store real estate in a shifting retail landscape.
Dutch Bros has opened its first Los Angeles coffee shop near USC, filling a notable gap in its California footprint. The move highlights the brand’s youth-focused strategy and signals a cautious but meaningful push into dense urban markets.
DoorDash is piloting Zesty, a standalone AI-powered food discovery app in New York and the Bay Area. The move signals a shift from delivery-first search to concierge-style, personalized restaurant recommendations.
Central Perk Coffeehouse opens a permanent Times Square location, signaling how entertainment brands are transforming fandom into long-term experiential retail. Design, food strategy, and pop culture economics analyzed.
As AI shopping agents reshape ecommerce, retailers are forming a new coalition to retain customer relationships. We analyze the Shopper Context Protocol, why brands fear losing control to AI platforms, and what this shift means for the future of agentic commerce.
DXL and FullBeauty plan a merger to create a scaled leader in plus-size apparel. We analyze the deal’s structure, cost synergies, technology bets, and why GLP-1 weight-loss drugs are unlikely to derail long-term growth.
DXL and FullBeauty plan a merger to create a scaled leader in plus-size apparel. We analyze the deal’s structure, cost synergies, technology bets, and why GLP-1 weight-loss drugs are unlikely to derail long-term growth.
